Result
-€355,692 -€355,692
From profit to loss in 2024, after a profit of €13,149 in 2023.
FLANDERS.BIO
Lifetime
19 annual accounts with figures on one time axis, 20 filings since 2005peak €877,418 (2023)
€631,287▼ 28.1%
lowest -€355,692 (2024)
-€355,692▼ €368,841
peak €1.3m (2021)
€825,712▼ 30.1%
€339,964▼ 32.6%
peak 7.4 FTE (2016)
5.6 FTE▼ 16.4%
Board28 names since 2014all names
18 directorsBioMARIC NV and 17 others
Documentsfilings and deeds
10-06-202551 days before the deadline
2024abbreviated format
Turnover from €1.1m to €898,016Gross margin from €877,418 to €631,287Loss of €355,692Staff from 6.7 FTE to 5.6 FTE1 director resigning 24-07Equity from €1.2m to €825,712
Key points
from the 2024 annual accounts, the last ones filedInvestments
€82,872 2.0 × depreciation
Green is investment, beige is depreciation.
Staff
6 employees on 31-12-2024
In 2024, 3 people joined and 3 left.
Payment terms
48 days to suppliers
FLANDERS.BIO pays its suppliers 17 days later than in 2023. Customers pay 35 days earlier.
Liquidity
6.17 was 10.35 in 2023
Short-term debts rose from €159,447 to €176,433.
Public support
€180,000 awarded from 2022 to 2024
Flemish support, mostly Subsidies voor internationaal ondernemen.
No score
Board and ownership
BN
2 Bridge NV
Director, Ann Meulemans
NP
NV PMV
Director, Kenneth Wils
BB
BASF Belgium Coordination Center CommV
Director, Erik van der Biezen
JP
Janssen Pharmaceutica NV
Director, Tom Aelbrecht
KS
KBC Securities NV
Director, Nathalie Van Den Haute
Recent changes
Merger: absorbed by FBM
Dissolution of the company · Dissolved without liquidation · General meeting of 13-02-2025 · Gazette deed
Listed in the Peppol Directory
5 directors appointed, 1 resignation
Resignation: Wouter Piepers (day-to-day manager) · Appointments: Vibio (day-to-day manager), Montis Biosciences, 2 Bridge NV, PMV NV and QbD Flanders NV · Permanent representatives: Patrik De Haes, Danny Gonnissen, Philippe De Backer, Bernard Sagaert, Ann Meulemans, Kenneth Wils and 4 others · Board meeting of 28-11-2024 · Gazette deed
1 director resigning
Permanent representatives: Marieke Vermeersch and Erik Present · Willem Dhooge (day-to-day manager) · Board meeting of 18-06-2024 · Gazette deed
Official details
Source: KBO- Status
- Absorbed by FBMmerger by absorption, March 2025
- Activity
- No activity registered in the KBO
- Joint committee
- 335Services and support for business and the self-employed · annual accounts 2022
- Financial year end
- 31 December
- Peppol
- Reachable since 25-02-2025
Insights on FLANDERS.BIO
Absorbed by FBM in March 2025. The last annual accounts are for financial year 2024. The company was dissolved without liquidation.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FLANDERS.BIO
- What is the company number of FLANDERS.BIO?
- The company number of FLANDERS.BIO is 0863.763.620. The VAT number is the same number with BE in front: BE 0863.763.620.
- What is the legal form of FLANDERS.BIO?
- Legal form of FLANDERS.BIO: VZW.
- Is FLANDERS.BIO still active?
- No. FLANDERS.BIO is inactive in the KBO register.Company details
- How many employees did FLANDERS.BIO have?
- FLANDERS.BIO had an average of 5.6 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does FLANDERS.BIO fall under?
- In its 2022 annual accounts, FLANDERS.BIO states joint committee 335 (Services and support for business and the self-employed).
- What is the turnover of FLANDERS.BIO?
- The turnover of FLANDERS.BIO was €898,016 in financial year 2024, according to the filed annual accounts.
- Is FLANDERS.BIO profitable?
- In financial year 2024, FLANDERS.BIO made a loss of €355,692.
- Where can I find the annual accounts of FLANDERS.BIO?
- FLANDERS.BIO filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2024.